Urology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Connolly RM et al. - Phase 3 trials investigating high-dose chemotherapy plus stem cell transplantation as a first-line strategy for poor-prognosis advanced germ cell cancer and as salvage therapy have failed to indicate a survival advantage over conventional chemotherapy.

Related Articles

Testicular cancer: addressing the psychosexual issues
British Journal of Nursing, 10/27/09    Relevance Score: 70%

New Drug Aims To Seek And Destroy Many Types Of Cancer
ScienceDaily, 10/07/09    Relevance Score: 69%

New drug aims to seek and destroy many types of cancer
EurekAlert, 10/06/09    Relevance Score: 69%

Hypogonadism Risk in Men Treated for Childhood Cancer
Internet Source, 11/05/09    Relevance Score: 68%

The predictive value of testicular ultrasound abnormalities for carcinoma in situ of the testis in men at risk for testicular cancer
International Journal of Andrology, 10/23/09    Relevance Score: 68%

Today in Oncology...keeping you current

Management of patients with advanced bladder cancer following major response to systemic chemotherapy
Expert Review of Anticancer Therapy, 12/04/09

Degarelix 240/80 mg: a new treatment option for patients with advanced prostate cancer
Expert Review of Anticancer Therapy, 12/04/09

The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer
Cancer Treatment Reviews, 12/04/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address